Lantz Financial’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,802	Closed	-$215K	–	235
2024 Q3	$215K	Sell	1,802 -9	-0.5%	-$1.07K	0.06%	212
2024 Q2	$259K	Buy	1,811 +70	+4%	+$9.99K	0.08%	179
2024 Q1	$224K	Buy	+1,741	New	+$224K	0.07%	190